CSIMarket
 
Harvard Apparatus Regenerative Technology Inc   (BSTG)
 

Harvard Apparatus Regenerative Technology Inc's Customers Performance

BSTG



 
BSTG's Source of Revenues During the corresponding time, Harvard Apparatus Regenerative Technology Inc recorded a revenue increase by 402.22 % year on year, sequentially revenue grew by 3.2 %. While revenue at the Harvard Apparatus Regenerative Technology Inc 's corporate clients

List of BSTG Customers




for the same period Harvard Apparatus Regenerative Technology Inc recorded revenue increase by 402.22 % year on year, sequentially revenue grew by 3.2 %.

List of BSTG Customers

Harvard Apparatus Regenerative Technology Inc's Business Units
Consumer Health Products    283.19 % of total Revenue






Harvard Apparatus Regenerative Technology Inc's Comment on Sales, Marketing and Customers



The company primarily serves major hospitals in the United States, Asia, and Europe, focusing on surgeries involving esophageal implants. Its technology is designed for the treatment of the esophagus, bronchi, and trachea, procedures typically performed by thoracic surgeons. Hospitals are expected to be the company's direct customers, with reimbursement sought from government payers, private health insurers, and other third-party payers. For its Consumer Health Products, the company has granted exclusive global distribution rights to Health Regen, Inc., based in Pittsfield, Massachusetts, under an agreement effective from November 1, 2024, through December 31, 2030.





Harvard Apparatus Regenerative Technology Inc’s Comment on Sales, Marketing and Customers


The company primarily serves major hospitals in the United States, Asia, and Europe, focusing on surgeries involving esophageal implants. Its technology is designed for the treatment of the esophagus, bronchi, and trachea, procedures typically performed by thoracic surgeons. Hospitals are expected to be the company's direct customers, with reimbursement sought from government payers, private health insurers, and other third-party payers. For its Consumer Health Products, the company has granted exclusive global distribution rights to Health Regen, Inc., based in Pittsfield, Massachusetts, under an agreement effective from November 1, 2024, through December 31, 2030.








BSTG's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Harvard Apparatus Regenerative Technology Inc 78.23 0.89 -6.81 8
SUBTOTAL 0.00 0.00 0.00 -

Sources: Harvard Apparatus Regenerative Technology Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Harvard Apparatus Regenerative Technology Inc’s corporate clients.
For your research, we’ve provided 9 tables on Harvard Apparatus Regenerative Technology Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.